High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network (Q35619221)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2012

Language	Label	Description	Also known as
English	High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network	scientific article published on January 2012

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

autism spectrum disorder

0 references

1 reference

based on heuristic

inferred from title

author name string

Sarah L Logan

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Joyce S Nicholas

2

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Laura A Carpenter

3

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Lydia B King

4

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Elizabeth Garrett-Mayer

5

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Jane M Charles

6

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

publication date

1 January 2012

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Annals of Epidemiology

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

22

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

1-8

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

Completeness of case ascertainment for surveillance of autism spectrum disorders using the autism developmental disabilities monitoring network methodology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Evaluation of a records-review surveillance system used to determine the prevalence of autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007-2008.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Omega 3 fatty acid treatment in autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

State variation in psychotropic medication use by foster care children with autism spectrum disorder

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Autism spectrum disorders in preschool-aged children: prevalence and comparison to a school-aged population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

A longitudinal investigation of psychotropic and non-psychotropic medication use among adolescents and adults with autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Complementary and alternative medicine treatments for children with autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

alpha2-Adrenergic receptor agonists for the treatment of attention-deficit/hyperactivity disorder: emerging concepts from new data

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Medication Use Among Children with Autism Spectrum Disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Prevalence of autism spectrum disorders--autism and developmental disabilities monitoring network, 14 sites, United States, 2002.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Examination of the time between first evaluation and first autism spectrum diagnosis in a population-based sample

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Factors associated with age of diagnosis among children with autism spectrum disorders

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Internet survey of treatments used by parents of children with autism

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Medication patterns in patients with autism: temporal, regional, and demographic influences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Guanfacine treatment of hyperactivity and inattention in pervasive developmental disorders: a retrospective analysis of 80 cases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Analysis of data with excess zeros

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

12 July 2018

Prevalence and characteristics of children with autism-spectrum disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

A comparison of health care utilization and costs of children with and without autism spectrum disorders in a large group-model health plan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

Treatment incidence and patterns in children and adolescents with autism spectrum disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

Multiple psychotropic medication use for youths: a two-state comparison

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

Multiple psychotropic pharmacotherapy among child and adolescent enrollees in Connecticut Medicaid managed care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

Comparisons of two-part models with competitors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

Higher-functioning pervasive developmental disorders: rates and patterns of psychotropic drug use.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3240812

25 September 2018

Identifiers

10.1016/J.ANNEPIDEM.2011.10.007

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35619221&oldid=1859527105"